A cortisol-secreting adrenocortical tumour (ACT) is the cause of naturally occurring canine hypercortisolism in approximately 15% to 20% of cases. The differentiation between an adrenocortical adenoma and carcinoma is usually based on histopathology. However, histopathological parameters have never been linked to the dogs' survival. Moreover, in human medicine the inter-observer variability of some histopathological parameters that are used for ACTs is high.
| INTRODUCTION
Naturally occurring hypercortisolism is one of the most common endocrine disorders in dogs. It is caused by a cortisol-secreting adrenocortical tumour (ACT) in approximately 15% to 20% of cases, for which the treatment of choice is adrenalectomy, if no metastases can be detected. 1 Without the presence of metastases, assessing the malignancy of an ACT remains challenging. The differentiation between an adrenocortical adenoma (ACA) and adrenocortical carcinoma (ACC) is usually based on histopathology. Although several studies have been conducted on the histopathological analysis of human ACTs, [2] [3] [4] [5] [6] [7] [8] [9] the literature on canine ACTs is less extensive. The most recent study on histopathology of canine ACTs was published in 2004, in which the authors compared a number of histopathological criteria between ACAs and ACCs. 10 The criteria that were determined to be diagnostically useful included tumour size, peripheral fibrosis, capsular invasion, trabecular growth pattern, haemorrhage, necrosis, single-cell necrosis, haematopoiesis, fibrin thrombi, cytoplasmic vacuolation and the proliferation index by use of the Ki67 marker. 10 However, whether the presence or absence of these parameters was associated with poor survival times has not been assessed. Moreover, the parameters used in this study were analysed by only one pathologist, 10 whereas in the classification of human ACTs the inter-observer variability is known to be high for some of these parameters. 2, 3 In humans, the most widely used histopathological scoring system to differentiate ACCs from ACAs is the Weiss score. In this system, the presence of three or more out of nine established histopathologic criteria indicates malignant potential. 6, 7 Although the Weiss score can diagnose an ACC with high sensitivity and specificity, some of the criteria included suffer from inter-observer variation and require evaluation by an experienced endocrine pathologist. 2, 3 To reduce this inter-observer variation, other scoring systems such as the Weiss revisited score 3 and the Helsinki score 2 have been proposed. In addition, several studies have shown the value of immunohistochemical staining for the proliferation marker Ki67 to differentiate between ACAs and ACCs. 3, [11] [12] [13] [14] In humans, the prognosis of patients with an ACC does not only differ from that of patients with an ACA, but the prognosis also varies greatly within the group of patients with an ACC. 8, 15 In human ACCs, histopathological criteria that are associated with a poor prognosis include high mitotic rate, high Ki67 proliferation index (PI), and high Helsinki score. 7, 8, 16, 17 The objective of this retrospective study was to establish a reliable and easy-to-use histopathological scoring system for cortisolsecreting ACTs that can assess the prognosis of dogs after adrenalectomy.
| MATERIALS AND METHODS

| Case selection
Canine cortisol-secreting ACTs were collected between 2002 and 2015. Permission to use the ACT tissue was obtained from all dog owners. The suspicion of hypercortisolism was based on the presence of clinical signs and routine laboratory findings consistent with hypercortisolism. Non-suppressible hypercortisolism was diagnosed using the low-dose dexamethasone suppression test, or urinary corticoid: creatinine ratios (UCCRs) combined with a high-dose dexamethasone suppression test. 18 The presence of an adrenal tumour was visualized by abdominal ultrasonography, computed tomography, or both. All dogs underwent unilateral adrenalectomy, which was performed by one of four experienced veterinary surgeons. Dogs were excluded from the study when they were euthanized or died before, during, or within 2 weeks after adrenalectomy; when the dog had bilateral adrenal tumours; when metastases were detected before or at time of surgery; when no formalin-fixed paraffin-embedded tissue was available; and when less than 3 months of follow-up information was available.
| Clinical parameters
The dogs' medical records were retrospectively reviewed for dogrelated parameters, clinical tumour-related parameters and surgeryrelated parameters. Dog-related parameters included sex and neutering status, body weight, age at time of surgery and preoperative treatment for hypercortisolism. Tumour-related parameters included the location of the tumour (left or right), whether there was evidence of venous invasion seen during diagnostic imaging or during surgery, and the tumour diameter (not including normal adrenal tissue). Measurement of the tumour diameter was performed during diagnostic imaging (ultrasound or CT) and/or after surgery. Surgery-related parameters included the duration of the surgery, and whether the tumour capsule ruptured during surgery.
| Histopathological parameters
The ACTs were collected within 10 minutes after surgical removal. A representative section of the tumour was fixed in formaldehyde for histopathology and immunohistochemistry, the remaining tumour sections were used for other research purposes. The tissues were fixed in 4% buffered formaldehyde for 24 to 48 hours, embedded in paraffin, and cut into 4-μm sections. One tissue section for each ACT was sta- twice as large: 2), the size that predominated was recorded. The nuclear grade was evaluated as described by Fuhrman et al. (1982) . 19 All histopathological parameters were visually estimated in the entire tissue section using a light microscope, no image analysis was performed. Both observers assessed the tissue sections twice at separate time points, and were blinded to the clinical data. 
| Ki67 proliferation index
| Analyses
The intra-and inter-observer agreement scores for histopathological parameters and the Ki67 PI were quantified using the intra-class correlation coefficient (ICCC) for continuous variables, and Cohen's kappa coefficient for categorical variables. The strength of agreement was interpreted as follows: <0.40, poor; 0.40-0.59, modere; 0.60-0.79, good; 0.80-1.00, excellent. 21 Only parameters with an agreement score of more than 0.40 in all areas (ie, intra-observer agreement of both observers, and inter-observer agreement) were included in survival analyses. In case of continuous variables, the results of all four observations (ie, two observations per observer) were averaged for further analyses. In case of categorical variables, the result that was most prevalent was noted. If this could not be established, the parameter was scored again for these slides and the final outcome was noted.
Dogs were considered to have died as a result of the ACT when they were euthanized because of metastases or comorbidities related to recurrence of hypercortisolism. Recurrence of hypercortisolism was confirmed by the presence of hypercortisolism-related clinical signs and elevated UCCRs, which could be either because of regrowth of the ACT or metastases. For each dog, survival time was calculated from the time of surgery to euthanasia because of recurrence. If a dog died from unrelated causes, was lost to follow-up, or was still alive at the end of the study, then the dog was censored and the last known date that the dog was still alive was used as censoring date.
Univariate analyses were performed with the Cox proportional hazards model. All variables that had a P value of <0.15 in the univariate analyses were subsequently included in multivariate stepwise regression with forward selection. Optimal cut-off values were calculated with receiver operating characteristic curves. The value with the highest Youden index (sensitivity + specificity − 1) was selected as the optimal cut-off value. Survival times were calculated using the Kaplan-Meier product-limit method. The log-rank method was used to calculate if differences between groups were significant. P values of <0.05 were considered significant. All statistical analyses were performed with SPSS Statistics for Windows (Version 24.0, IBM Corp, Armonk, New York).
| RESULTS
| Cases
A total of 50 dogs were included in the study. The most represented dog breeds were Labrador Retriever (5), Dachshund (5), Jack Russel Terrier (4), Schnauzer (2), Maltese (2), Fox Terrier (2) and White Shepherd (2) . Of the remaining dogs, 11 were mixed-breed dogs and 17 were of breeds that were represented once. Information on additional dog-related parameters is included in Table 1 .
The estimated median survival time after adrenalectomy for all 50 dogs as calculated by the Kaplan-Meier method was 54.7 months (95% CI 47.1-62.2 months) ( Figure 1A ). Of the 50 dogs, 19 were known to have had recurrence of hypercortisolism. The median survival time of these 19 dogs with recurrence was 16.9 months (95% CI 10.8-49.3 months). All 31 dogs that had no recorded recurrence were censored in the survival analyses so no estimated median survival was reached using the Kaplan-Meier method, but the median follow-up time was 27.1 months (95% CI 15.4-42.0 months).
| Clinical parameters
Of all clinical parameters that were analysed, only the tumour diameter was significantly associated with survival (univariate analysis, Table 1 ). The optimal cut-off value was approximately 3 cm, which resulted in a significant (P = 0.034) difference in survival times between dogs with an ACT ≥3 cm (n = 18, estimated median survival time 24.2 months, 95% CI 1.3-47.1 months) and dogs with an ACT <3 cm (n = 28, estimated median survival time 54.7 months, 95% CI 48.2-61.1 months) ( Figure 1B ). Cut-off values of 2 or 5 cm as previously suggested in literature 10, 22 did not result in significant differences in survival times (P = 0.255 and P = 0.172, respectively).
| Histopathological parameters and Ki67 PI
In assessing intra-and inter-observer reliability, four histopathological parameters had agreement scores of more than 0.4 in all areas (ie, intra-observer agreement scores for both observers, and interobserver agreement score): decreased reticulin fibre density (Figure 2A , lowest agreement score 0.56, P < 0.001), extramedullary haematopoiesis ( Figure 2B , lowest agreement score 0.59, P < 0.001), clear/vacuolated cytoplasm ( Figure 2C and D, lowest agreement score 0.67, P < 0.001) and necrosis ( Figure 2E , lowest agreement score 0.51, P < 0.001). No intra-observer agreement scores could be calculated for the Ki67 PI ( Figure 2F ) because both observers assessed all ACTs once, but the inter-observer agreement score was excellent (0.96, P < 0.001). All intra-and inter-observer agreement scores are provided in Supporting Information Table S1 .
In assessing the potential of the histopathological parameters as prognostic indicators, three parameters were significantly associated with survival according to univariate analyses (Table 2) : the percentage of 
| The Utrecht score
To determine which parameters were independent predictors of poor survival, we used multivariate logistic regression with forward selection.
This indicated that the Ki67 PI, clear/vacuolated cytoplasm in at least 33% of the tumour cells, and the presence of necrosis were all independent predictors of survival. Based on their hazard ratios in the multivariate analysis ( Figure 3 ).
The median Utrecht score was 7.1 (range, 0.4-29.2), and the optimal cut-off value was approximately 6. To further divide the ACTs with scores of 6 or higher into two groups with different survival times, we used a cut-off value of 11, which was calculated as the approximate optimal cut-off value in the subset of patients with scores of more than 6. We then categorized the ACTs according to their Utrecht score in three groups: (1) Utrecht score < 6 (n = 17), (2) Utrecht score ≥ 6 to <11 (n = 22) and (3) Utrecht score ≥ 11 (n = 11). As illustrated in 
| DISCUSSION
Here we introduce the Utrecht score: a novel histopathological scoring system that can assess the prognosis of dogs with a cortisolsecreting ACT after adrenalectomy. With cut-off values of 6 and 11, we could distinguish three groups that had significantly shorter survival times with increasing scores. We propose to classify ACTs with a score of <6 as having low risk of recurrence, with a score of ≥6 to <11 as having moderate risk of recurrence, and with a score of ≥11
as having high risk of recurrence.
Because most veterinary pathologists will not encounter an ACT on a daily basis, histopathological assessment of an ACT ideally should not require extensive training. In this study, 20 histopathological parameters were scored twice by both an experienced veterinary pathologist and a resident in veterinary pathology. This allowed us to include only those parameters that turned out to have low intra-and inter-observer variability irrespective of the observers' experience, thereby improving the reliability of the Utrecht score.
A recent study on human ACCs reported low intra-and interobserver agreement scores for Ki67 scoring among 14 trained endocrine pathologists. 23 However, in that study each observer was allowed to perform the analyses according to their own method of preference, which included visual estimation, formal manual count, and digital image analysis. In our study, the inter-observer agreement of the Ki67 PI was excellent, which is most likely associated with the methodology used. To standardize Ki67 PI scoring as much as possible, we suggest to analyse the Ki67 PI in hot spot areas, to capture images of these areas, to count at least 1000 nuclei, and to use ImageJ 20 or similar software to keep track of the number of counted positive and negative cells. A drawback of this method is that it is 25 Since cholesterol, which could be stored in these lipid droplets, functions as substrate for all steroid hormones, the percentage of cells with clear/vacuolated cytoplasm could be related to the production of cortisol or its precursors. In human ACTs, cortisol production is known to be a negative prognostic indicator. 26, 27 In our study, however, only cortisol-secreting ACTs were included so the presence or absence of hypercortisolism was not a variable, but the percentage of cells with clear/vacuolated cytoplasm could have been related to the degree of hypercortisolism. Because different methods or assays were used to establish hypercortisolism, we were unable to test this hypothesis. For future studies it would be interesting to determine whether clear/vacuolated cytoplasm is indeed related to the degree of cortisol production, since this would also indicate that non-secreting ACTs might be less malignant overall than cortisolproducing ACTs.
Of the clinical parameters, only the tumour diameter was significantly associated with survival. However, it did not retain its significance in the multivariate analysis, neither on a continuous scale nor when using the indicated cut-off value. Although this means that it is not an independent predictor of survival after surgery, it is currently the only parameter that can give an assessment of prognosis before surgery. We showed that dogs with a tumour diameter of ≥3 cm had significantly worse survival times after adrenalectomy than those with a diameter of <3 cm. Although previous studies reported that cut-off values of 2 cm 10 or 5 cm 22 should be used, classification based on these values did not result in significantly different survival times in our study. In some studies tumour size was not significantly associated with survival time. 28, 29 For future studies it might be useful to determine whether measurement of the tumour volume has additional prognostic value compared to measurement of the tumour diameter.
In this study we assessed whether the evaluated parameters can predict long-term survival. What we therefore did not assess was whether these parameters influence perioperative or short-term survival. For example, although venous invasion as observed during imaging or surgery does not seem to affect long-term survival, as also reported in other studies, 30, 31 it could complicate the surgical procedure. Indeed, extensive invasion of the tumour into the caudal vena cava when the tumour thrombus extends beyond the hepatic hilus has been reported to increase perioperative mortality. 31 In other studies, however, the presence of venous invasion did not affect perioperative mortality, 10,30 so this possibly depends on the extent of invasion, the experience of the surgeon, and/or whether 25% of the tumour is a negative prognostic factor, 3,6 similar to previously described in canine ACTs, 10 whereas in the Utrecht score more than 33% tumour cells with clear/vacuolated cytoplasm is a negative prognostic factor. Clear cytoplasm was, however, reported to be the least useful criterion in the Weiss score. 6 In both the human and canine previous studies, cases with an ACT were selected irrespective of their hormonal status, 3,6,10 whereas we included only cortisolsecreting ACTs. Whether this discrepancy in morphology of cytoplasm is related to a difference in assessment, interpretation or both, or to differences in the hormonal status of the ACT, remains to be elucidated.
A weakness of this study is its retrospective nature. Not all information had been documented consistently, for example, information on the tumour diameter was missing in four cases, and measurement of the tumour diameter was not standardized. Moreover, we were not able to reliably calculate tumour volumes because the multiple dimensions of the tumour were not often documented, nor was the tumour weight, which has prognostic value in human ACTs. 9 The study's retrospective nature could also have affected the reported survival times of the dogs, which were sometimes based on the owner's estimate of when their dog had died. In addition, the reason for recurrence was not investigated in every case, so we could not make a distinction between local recurrence and recurrence because of metastases.
Another remark is that although ACTs can be highly heterogeneous, all histopathological parameters and the Ki67 PI have been assessed on just one tissue section of the ACT because of the retrospective nature of this study. If the most malignant area of the tumour was not included in this tissue section, this could have resulted in an underestimation of the malignancy grade. However, even with just one tissue section the Utrecht score was able to distinguish three groups with significantly different survival times.
Although the fact that we only included parameters with intraand inter-observer agreement scores of ≥0.4 improves the reliability of the scoring system, a drawback is that we may have excluded factors that are important prognostic parameters. Moreover, the method used to create the Utrecht score has based its calculations on this specific subset of patients. To verify the validity of the score, a large prospective multi-institutional study in other patient groups and with the participation of more veterinary pathologists is required.
Additionally, in this study we only included cortisol-secreting ACTs, and whether the score can also be a valuable prognostic tool in, for example, non-secreting ACTs will have to be determined in future studies.
In conclusion, we introduce the Utrecht score to post-surgically assess the prognosis of dogs with cortisol-secreting ACTs. Having an accurate assessment of prognosis is useful to communicate to the dog's owner, but could also assist in selecting high-risk dogs that might benefit from additional monitoring, adjuvant therapy with, for example, mitotane, or both. Moreover, a solid histopathological scoring system represents a basis for future studies on other markers of malignancy, which could facilitate the identification of potential future treatment targets.
